- Both donors and recipients were advised to practice proper COVID-19 protective measures both before and after surgery including mask wearing and regular bodily disinfection
- Both parties also received regular testing prior to surgery
- Most actions taken by both parties were extremely similar to guidelines for transplantation donors and recipients prior to the COVID-19 era, but with more caution


Ohio State University, Columbus

- This article seeks to detail some of the experience of providing kidney transplants in a few centers located in India during the COVID-19 pandemic
- This article is a retrospective study and mainly seeks to look at patient outcome from procedures done during the pandemic using mainly hospital system information and medical records
- Patient assessments were primarily made on the basis of case severity, need for patient ventilation, mortality, graft dysfunction, graft loss and rejection rates


A retrospective multi-center experience of renal transplants from India during COVID-19 pandemic

Jha, P. K., Yadav, D. K., Siddini, V., Bansal, S. B., Sharma, R., Anandh, U., Jeloka, T., Reddy, S., Pokhariyal, S., Nandwani, A., Jain, S., Saxena, V., Sethi, S. K., Bansal, D., Jain, M., Sodhi, P., Gadde, A., Augustine, R., Zafar, F. A., … Kher, V. (2021). A retrospective multi‐center experience of renal transplants from India during COVID‐19 pandemic. Clinical Transplantation, ctr.14423. https://doi.org/10.1111/ctr.14423

URL: https://onlinelibrary.wiley.com/doi/10.1111/ctr.14423

Donor Recipient Workup

- Overall survivability rates remained fairly high, with 14 mortalities out of 297 transplants
- Most deaths came from cardiac complication and most post-surgery infections were from COVID-19
- 12 recipients and 7 donors contracted COVID-19 prior to their scheduled surgeries
- 41 transplant recipients contracted COVID-19 after their surgeries
- It was also noted that recipients that contracted COVID-19 were significantly older part of the population than those that did not 
- In COVID-19 transplant patients respiratory symptoms predominated
- To treat comorbid patients various drugs such as remdesivir, lopinavir/ritonavir, hydroxychloroquine, dexamethasone, azithromycin, tocilizumab, convalescent plasma were used with no clear evidence to favor the use of a specific drug


Learn Before

Related